JP2022545836A5 - - Google Patents

Info

Publication number
JP2022545836A5
JP2022545836A5 JP2022513571A JP2022513571A JP2022545836A5 JP 2022545836 A5 JP2022545836 A5 JP 2022545836A5 JP 2022513571 A JP2022513571 A JP 2022513571A JP 2022513571 A JP2022513571 A JP 2022513571A JP 2022545836 A5 JP2022545836 A5 JP 2022545836A5
Authority
JP
Japan
Application number
JP2022513571A
Other languages
Japanese (ja)
Other versions
JP7671738B2 (ja
JPWO2021041392A5 (https=
JP2022545836A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/047767 external-priority patent/WO2021041392A1/en
Publication of JP2022545836A publication Critical patent/JP2022545836A/ja
Publication of JP2022545836A5 publication Critical patent/JP2022545836A5/ja
Publication of JPWO2021041392A5 publication Critical patent/JPWO2021041392A5/ja
Application granted granted Critical
Publication of JP7671738B2 publication Critical patent/JP7671738B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022513571A 2019-08-26 2020-08-25 Jak1阻害剤として有用な置換(7h-ピロロ[2,3-d]ピリミジン-4-イル)アミノ化合物 Active JP7671738B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962891706P 2019-08-26 2019-08-26
US62/891,706 2019-08-26
PCT/US2020/047767 WO2021041392A1 (en) 2019-08-26 2020-08-25 Substituted (7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino compounds useful as jak1 inhibitors

Publications (4)

Publication Number Publication Date
JP2022545836A JP2022545836A (ja) 2022-10-31
JP2022545836A5 true JP2022545836A5 (https=) 2023-09-06
JPWO2021041392A5 JPWO2021041392A5 (https=) 2023-09-06
JP7671738B2 JP7671738B2 (ja) 2025-05-02

Family

ID=74685810

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513571A Active JP7671738B2 (ja) 2019-08-26 2020-08-25 Jak1阻害剤として有用な置換(7h-ピロロ[2,3-d]ピリミジン-4-イル)アミノ化合物

Country Status (9)

Country Link
US (1) US12492204B2 (https=)
EP (1) EP4021452B1 (https=)
JP (1) JP7671738B2 (https=)
CN (1) CN114761011B (https=)
AU (1) AU2020338043B2 (https=)
CA (1) CA3152021A1 (https=)
ES (1) ES2974946T3 (https=)
PL (1) PL4021452T3 (https=)
WO (1) WO2021041392A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020338043B2 (en) * 2019-08-26 2025-12-18 Chemwerth, Inc. Substituted (7H-pyrrolo[2,3-D]pyrimidin-4-yl)amino compounds useful as JAK1 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101667822B1 (ko) * 2008-04-30 2016-10-19 내셔날 헬스 리서치 인스티튜트 오로라 키나아제 저해제용 접합 2고리 피리미딘 화합물
CA2776028C (en) 2009-10-15 2015-12-01 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds
KR102032934B1 (ko) * 2011-12-21 2019-10-16 지앙수 헨그루이 메디슨 컴퍼니 리미티드 피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도
US9926327B2 (en) 2016-02-16 2018-03-27 Zoetis Services Llc Process for preparing 7H-pyrrolo[2,3-D]pyrimidine compounds
JP6944496B2 (ja) 2018-10-22 2021-10-06 ファイザー・インク ピロロ[2,3−d]ピリミジントシル酸塩、その結晶形態、ならびにその製造方法および中間体
AU2020338043B2 (en) * 2019-08-26 2025-12-18 Chemwerth, Inc. Substituted (7H-pyrrolo[2,3-D]pyrimidin-4-yl)amino compounds useful as JAK1 inhibitors

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021015500A2 (https=)
JP2022545836A5 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)
BR102021016200A2 (https=)
BR102021015566A2 (https=)
BR102021015450A8 (https=)
BR102021015220A2 (https=)
BR102021015247A2 (https=)
BR112023008622A2 (https=)
CN305535074S (https=)
CN305530867S (https=)